Good Laboratory Practices (GLP) compliant: validated by AFSSAPS every other year:

ICHS7A: Guideline on safety pharmacology studies for human pharmaceuticals
Step 5, July 2001
ICHS7B: Guideline on Safety Pharmacology studies for assessing the potential for delayed ventricular
repolarisation (QT interval prolongation) by human pharmaceuticals
Step 4, May 2005
Seen as an extension of S7A.

